How will this be 'weaponised' under Greg Hunt's successors

November 6, 2019 Comment

This is a preview of subscriber content

Subscribe now to continue reading.

If a government's acceptance of the 'conditionality' of PBAC recommendations becomes fact today, which it will unless corrected, what will be the consequences under Mr Hunt's successors? …

Subscribe now to continue reading.

Latest Video

New Stories

Donald Trump announces 'MFN' deal with Lilly and Novo Nordisk and end to 'global freeloading'
November 7, 2025 - - Latest News
Sanofi employees contribute over 400 volunteer hours to community and environmental causes
November 6, 2025 - - Latest News
Neuren posts record royalties as DAYBUE sales surpass US$100 million in third quarter
November 6, 2025 - - Australian Biotech
US Ambassador warns UK risks losing pharma investment unless it pays more for medicines
November 6, 2025 - - Latest News
Pfizer to continue legal fight as court rejects bid to block Novo Nordisk’s Metsera takeover bid
November 6, 2025 - - Latest News
What next for PBS rebate system amid constitutional breaches, disputed claims, and global pressure?
November 6, 2025 - - Latest News
Linda Burney to chair new First Nations Pharmacy Network
November 5, 2025 - - Latest News

How will this be 'weaponised' under Greg Hunt's successors

This is a preview of subscriber content

Latest Video

Most Read

Rebates are bad enough without invoices based on unconstitutional benefit claims

Sandoz launches PBS-listed ADHD medicine to help ease national supply shortages

Hong Kong positions itself as a global bridge for biotech and life sciences innovation

NDIS growth begins to slow but spending still tops $46 billion

Dr Andrée Bates on pharma’s real AI challenge - if the technology is ready, why isn’t the culture?

New Stories

Donald Trump announces 'MFN' deal with Lilly and Novo Nordisk and end to 'global freeloading'

Sanofi employees contribute over 400 volunteer hours to community and environmental causes

Neuren posts record royalties as DAYBUE sales surpass US$100 million in third quarter

US Ambassador warns UK risks losing pharma investment unless it pays more for medicines

Pfizer to continue legal fight as court rejects bid to block Novo Nordisk’s Metsera takeover bid

What next for PBS rebate system amid constitutional breaches, disputed claims, and global pressure?

Linda Burney to chair new First Nations Pharmacy Network

Sign In

How will this be 'weaponised' under Greg Hunt's successors

This is a preview of subscriber content

Latest Video

Most Read

Rebates are bad enough without invoices based on unconstitutional benefit claims

Sandoz launches PBS-listed ADHD medicine to help ease national supply shortages

Hong Kong positions itself as a global bridge for biotech and life sciences innovation

NDIS growth begins to slow but spending still tops $46 billion

Dr Andrée Bates on pharma’s real AI challenge - if the technology is ready, why isn’t the culture?

Follow Us

New Stories

Donald Trump announces 'MFN' deal with Lilly and Novo Nordisk and end to 'global freeloading'

Sanofi employees contribute over 400 volunteer hours to community and environmental causes

Neuren posts record royalties as DAYBUE sales surpass US$100 million in third quarter

US Ambassador warns UK risks losing pharma investment unless it pays more for medicines

Pfizer to continue legal fight as court rejects bid to block Novo Nordisk’s Metsera takeover bid

What next for PBS rebate system amid constitutional breaches, disputed claims, and global pressure?

Linda Burney to chair new First Nations Pharmacy Network